| Ticker Symbol: | ORCH |
|---|---|
| Exchange: | NASD |
| Contact Info: | 4390 US Route One Princeton NJ 08540 609 750-2200 |
| CEO/President: | Thomas A. Bologna M.D. |
| Industry: | Medical - Biomedical / Standard Industry Code: 8734 |
| Description: | Orchid Cellmark provides identity DNA testing services for the human identity and agriculture markets. In the human identity area, the company provides DNA testing services for forensic, family relationship and security applications. In the agriculture field, Orchid Cellmark provides DNA testing services for food safety and selective trait breeding. Orchid Cellmark\'s strong market positions in these segments reflect the company\'s accredited laboratories in the U.S. and U.K. and its innovative genetic analysis technologies and expertise. |
| Shares Outstanding: | 29,970 (000) | Market Value: | 25,770 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 80.69% | Number of Inst.Shareholders: | 2.80% |
| Last Quarter Sales: | 14.87 ($Mil.) | Last Quarter Net Income: | -1.46 ($Mil.) |
| Last Quarter EPS: | -0.05 | P/E Ratio: | 0 |
| Most Recent Earnings: | -0.05 on 10/30/08 | Earnings Per Share: | -0.16 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |

| AMGEN | +5.10 | 55.47 | |
| GILEAD SCIENCES | -8.10 | 44.45 | |
| CELGENE CP | -16.20 | 55.97 | |
| BIOGEN IDEC INC | -30.20 | 44.26 | |
| GENENTECH INC | +4.70 | 80.36 |
